Research Grant
[Cite as https://purl.org/au-research/grants/nhmrc/571162]Researchers: Dr Katie Dixon (Principal investigator)
Brief description Prostate cancer is highly aggressive, causing one death every 4 minutes. It is the most common tumour and is the second highest cause of cancer death in men in Western society. Once it escapes the prostate and spreads to other parts of the body it cannot be cured. Current treatment options are limited and cause debilitating side effects. In this study I will investigate a new class of anticancer drugs developed in my host laboratory for prostate cancer treatment.
Funding Amount $AUD 292,639.10
Funding Scheme Early Career Fellowships
Notes Peter Doherty Biomedical ECF
- nhmrc : 571162
- PURL : https://purl.org/au-research/grants/nhmrc/571162
